BigBear.ai vs. D-Wave Quantum: Which Technology Stock Is a Better Buy in 2026?

BigBear.ai generated FY2025 revenue of $127.7 million, down 19.3% year over year, and posted a $293.9 million net loss with negative free cash flow of $46.3 million; nearly 51% of revenue came from the U.S. government. D-Wave Quantum grew FY2025 revenue 178.5% to $24.6 million but recorded a $355.1 million loss and negative free cash flow of $75.8 million, while trading at a far higher 503.6x P/S multiple versus BigBear's 10.5x. The article favors BigBear.ai for its government-contract backlog, improving gross margins, and comparatively clearer route to sustainable revenue, while flagging its customer concentration, accounting restatements, and class-action litigation.

Analysis

The relevant distinction is not “AI versus quantum,” but funding durability versus equity-financing dependence. BBAI’s federal exposure can create lumpy procurement timing, yet classified-program incumbency and security-clearance requirements make a retained contract base harder to displace than commercial software revenue. The offset is that accounting restatements and litigation can delay awards, impair bid credibility, and prevent the multiple expansion normally associated with defense-AI narratives; reported margin and backlog trends should not be underwritten until audited filings reconcile prior periods.

QBTS remains principally a duration asset on quantum adoption rather than an earnings compounder. Its valuation leaves little tolerance for a conversion gap between announced bookings, pilot projects, and recurring cloud revenue; the likely financing need over the next 6-18 months creates dilution risk even if technical milestones are met. MSFT is a second-order beneficiary of enterprise quantum interest without single-platform commercialization risk, while MA, PFE, and SHL should be viewed as experiment partners rather than demand validation until deployments produce measurable production workloads.

Near term, both names will trade with retail AI/quantum momentum and capital-markets conditions more than fundamentals. Over 1-3 months, BBAI’s filing status, cash burn, and contract awards are the decisive catalysts; QBTS needs evidence that revenue conversion—not bookings growth alone—supports a reduced cash-burn trajectory. The contrarian view is that BBAI is not automatically the lower-risk long: a clean restatement may remove an overhang, but any revision that weakens backlog quality or liquidity could make its apparently lower sales multiple irrelevant.

Key Decisions for Investors

• Maintain no standalone core long in BBAI until restated financials are filed and management provides a reconciled backlog-to-revenue conversion schedule; initiate only if liquidity runway extends at least 12 months and FY revenue guidance is reaffirmed. Thesis fails on another filing delay, material revenue revision, or operating cash burn above guidance.
• For a tactical 1-3 month relative-value expression, consider long BBAI / short QBTS in equal beta-adjusted dollar amounts only after confirming QBTS borrow availability and cost. The trade targets valuation convergence as QBTS must prove conversion of commercial interest into revenue; stop if QBTS reports material recurring-revenue acceleration or BBAI discloses a restatement-driven contract or liquidity impairment.
• Prefer MSFT over pure-play quantum exposure for a 6-18 month allocation: it captures enterprise AI and quantum-services optionality while avoiding the binary hardware commercialization and dilution profile of QBTS. This is not a catalyst trade; reassess if hyperscaler quantum spending materially decelerates or a competitor establishes clear commercial quantum advantage.
• Set an alert around QBTS quarterly cash use, share count, and deferred-revenue/bookings conversion. A capital raise before sustained revenue realization would be a catalyst to add to a QBTS short or avoid long exposure; a demonstrable multi-quarter rise in recurring cloud revenue would invalidate the bearish relative-value thesis.